Category: ‘Clinical Trials and Studies’
Posted on January 25th, 2014
A Winnipeg paramedic has become the first Canadian to take part in an international clinical trial involving the treatment of spinal cord injuries using stem cells.
Alex Petric was injured last year during a winter vacation in Panama.
“I misjudged the water and just dove in,” the 29-year-old recalls. “I hit shallow water and became paralyzed immediately.”
Petric, now a paraplegic, became involved with the trial just four months after his injury.
Posted on August 4th, 2012
The FDA’s go-ahead makes The Miami Project’s clinical trial to aid against spinal cord injury the only one in the United States.
The Miami Project to Cure Paralysis said Tuesday it has received federal approval to conduct “revolutionary” human trials to transplant a patient’s own Schwann cells, found mainly in the nervous system, to the site of recent spinal cord injuries in the hope that the trials may bring researchers closer to finding a cure for paralysis.
Posted on September 24th, 2010
Northwestern Medicine is the first site open for enrollment in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury. Following the procedure, participants will receive rehabilitation treatment at The Rehabilitation Institute of Chicago (RIC).
Northwestern also is the lead site of the trial, sponsored by Geron Corporation. The trial eventually will include up to six other sites and enroll up to 10 participants nationally.
Posted on August 24th, 2010
The University of California, Irvine, has just completed the very first study to show that human stem cells can bring back movement in spinal cord injury, advocating the possibility of treatment for a more vast populace of patients.
Posted on August 10th, 2009
In what is seen as a boost to the stem cell research in the country, India would soon get to host human clinical trials for therapies using umbilical blood cord (UBC) stem cell.
Chennai-based Apollo Hospital, America’s largest stem cell company StemCyte and Dr Wise Young, a leading expert on spinal cord injury, are in talks for conducting clinical trials in India using stem cell derived from UBC. The companies may ink an agreement by the end of this year.